Questcor Pharmaceuticals (QCOR) produces and markets for all practical purposes a single product: H.P. Acthar Gel. Acthar is an injectable treatment for inflammatory disorders, particularly multiple sclerosis (MS) …
Gulfmark Offshore (GFL) Now Added to S&P SmallCap 600 Index - Analyst Blog Mallinckrodt Set to Join the S&P 500; Rowan to Join S&P MidCap 400; GulfMark Offshore to Join S&P SmallCap 600 Mallinckrodt Completes …
Questcor's stock leapt nearly 40% during trading yesterday as investors welcomed its $135m-plus purchase of Novartis' rival immune drug Synacthen. The US speciality pharma said it has bought rights to develop …
Good things keep happening to Questcor in the middle of the month. Here’s what’s notable: The middle of the month just happens to be the time that the company’s chief executive, Don M. Bailey, sells stock through his …
Stock
QCOR) common stock during the period between April 26, 2011 and September 21, 2012 (the "Class Period"). The complaint charges Questcor and certain of its officers and directors with violations of the Securities …
Lawsuit
Questcor shareholders will receive $30.00 per share in cash and 0.897 Mallinckrodt shares for each share of Questcor common stock they own, for a total approximate consideration of $86.10 per Questcor share. …
Shares of Questcor Pharmaceuticals Inc. are extending their decline in premarket trading Thursday after shedding nearly 50 percent of their value a day earlier when a research website said a major health insurer will stop …
Questcor was acquired by Mallinckrodt in 2014 for $5.8 billion. That Martin Shkreli was a key agent of MNK stock’s downfall on Wednesday for nearly the same doings that resulted in him being branded by many as the …
Shkreli
In a report published Tuesday, Mizuho Securities USA analyst Mario Corso reiterated a Buy rating and $93.00 price target on Questcor Pharmaceuticals (NASDAQ: QCOR). In the report, Mizuho Securities USA noted, “In …
The stock is trading 8.5% above its 50-day moving average and 15.4% above its 200-day moving average. While trading on below-average volume, Questcor Pharmaceuticals (QCOR) climbed today, reaching and then …